Cambrex Corporation. (CBM)
-NYSE 13.16 
0.03(0.23%) May 17, 4:02PM EDT
| Prev Close: | 13.13 |
|---|
| Open: | 13.18 |
|---|
| Bid: | 11.94 x 100 |
|---|
| Ask: | 14.30 x 2000 |
|---|
| 1y Target Est: | 16.00 |
|---|
| Beta: | 0.68 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 13.03 - 13.27 |
|---|
| 52wk Range: | 6.74 - 14.33 |
|---|
| Volume: | 115,779 |
|---|
| Avg Vol (3m): | 166,068 |
|---|
| Market Cap: | 395.21M |
|---|
| P/E (ttm): | 6.05 |
|---|
| EPS (ttm): | 2.17 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Cambrex Corporation. Passes This Key Testat Motley Fool(Wed, May 15)
- Cambrex To Present At UBS Global Healthcare ConferencePR Newswire(Mon, May 13)
- What Cambrex Corporation's Earnings Headlines Didn't Tell Youat Motley Fool(Mon, May 13)
- CAMBREX CORP FinancialsEDGAR Online Financials(Fri, May 10)
- How Cambrex Corporation. Got More Awesome Last Quarterat Motley Fool(Wed, May 8)
- 5 Healthcare Stocks Heading in Different Directions After Earningsat Wall St. Cheat Sheet(Sat, May 4)
- Cambrex. Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- Cambrex Earnings: Here’s Why Investors are Excited Nowat Wall St. Cheat Sheet(Fri, May 3)
- Cambrex Earnings Call scheduled for 8:30 am ET todayCCBN(Fri, May 3)
- Q1 2013 Cambrex Earnings Release - Before Market OpenCCBN(Fri, May 3)
- Cambrex Reports First Quarter 2013 Financial ResultsPR Newswire(Fri, May 3)
- CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 3)
- Convenience is Key in Cell Therapy Products: An Expert Analyst Discusses His Coverage of the Oncology and Cell Therapy Spaces with The Wall Street TranscriptWall Street Transcript(Wed, May 1)
- Cambrex To Announce First Quarter 2013 Financial Results On May 3, 2013PR Newswire(Tue, Apr 30)
- CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of SecuriEDGAR Online(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 13.85 |
|---|
| P/S (ttm): | 1.40 |
|---|
| Ex-Dividend Date: | 04-May-07 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.84 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.29 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 1.12 |
|---|
Business Summary
Cambrex Corporation operates as a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics worldwide.
View More